<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sexually Transmitted Infections (STIs)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' 
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="05-sbcc-and-hbc.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div> 
                        </div>
                       <span class="progress-text">Part 6 of 6</span> 
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Sexually Transmitted Infections (STIs)</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: sti-intro -->
                <section id="sti-intro" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Definition and Epidemiology</span>
                    </h2>
                    <div class="content-card">
                        <h3>Definition</h3>
                        <ul class="enhanced-list">
                            <li>The abbreviation STIs stand for sexually-transmitted infections</li>
                            <li>They are viral, bacterial or parasitic infections that are spread from person to person during sexual contact.</li>
                            <li>Other modes of transmission may be through blood transfusion, and from mother-to-child during pregnancy or delivery</li>
                            <li>There are so many STIs in the world which are curable but HIV is the most serious STI.</li>
                        </ul>

                        <h3>Epidemiology of STIs</h3>
                        <ul class="enhanced-list">
                            <li>More that 1 million people acquire STIs everyday around the world</li>
                            <li>The most common STIs in Kenya are;
                                <ol type="i">
                                    <li>Chlamydia</li>
                                    <li>Gonorrhoea</li>
                                    <li>Syphilis</li>
                                    <li>Herpes</li>
                                    <li>Genital warts</li>
                                    <li>Trichomonas vaginalis</li>
                                </ol>
                            </li>
                            <li>Chlamydia is the most prevalent, affecting mostly those aged 25-29 years.</li>
                            <li>Candidiasis is not considered a sexually transmitted infection, but it can be transmitted during vaginal intercourse</li>
                        </ul>
                    </div>
                </section>
                <!-- END: sti-intro -->

                <!-- START: risk-factors -->
                <section id="risk-factors" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Risk factors for STIs</span>
                    </h2>
                    <div class="content-card">
                        <h3>A. Behavioral risk factors</h3>
                        <ol class="enhanced-list">
                            <li>Having multiple sex partners</li>
                            <li>Sex with commercial sex workers</li>
                            <li>Having unprotected sexual intercourse</li>
                        </ol>

                        <h3>B. Biological Risk factors for STIs</h3>
                        <p>Biological risk factors include;</p>
                        <ol class="enhanced-list">
                            <li>Age</li>
                            <li>Sex of the individual</li>
                            <li>Low immune status of the host</li>
                            <li>Virulence of the organism causing STI</li>
                        </ol>

                        <h3>C. Socio-cultural Risk Factors for STIs</h3>
                        <ol class="enhanced-list">
                            <li>Occupations involving a lot of travelling e.g. long distance drivers</li>
                            <li>In some societies, where men's risky behavior of multiple sexual partners is tolerated</li>
                            <li>Early girl-child marriages to adults exposes the girl to infection</li>
                            <li>High numbers of single poorly paid and unemployed young people</li>
                            <li>Rural-urban migration</li>
                            <li>Sexual intercourse for pleasure and gain</li>
                        </ol>
                    </div>
                </section>
                <!-- END: risk-factors -->

                <!-- START: complications-transmission -->
                <section id="complications-transmission" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Complications and Transmission</span>
                    </h2>
                    <div class="content-card">
                        <h3>Complications Associated with STIs</h3>
                        <p>Failure to diagnose and treat STIs may result in serious complications</p>
                        <ol type="i" class="enhanced-list">
                            <li>Increased risk of acquiring HIV</li>
                            <li>They may cause infertility in both men and women</li>
                            <li>Increased risk to cervical cancers</li>
                            <li>They cause pregnancy complications e.g. ectopic pregnancy</li>
                            <li>Still birth</li>
                            <li>Neonatal conjunctivitis (ophthalmia neonatorum caused by maternal gonorrheoa)</li>
                            <li>Urethral stricture which can lead to renal failure in men</li>
                            <li>Painful intercourse</li>
                            <li>Congenital blindness & congenital malformations</li>
                            <li>Death- HIV infection within 10yrs or more or within 1-2yrs after onset of serious illness</li>
                        </ol>

                        <h3>Reasons why STIs are prevalent</h3>
                        <ol class="enhanced-list">
                            <li>Avoiding treatment
                                <ul>
                                    <li>Lack of symptoms- failure to recognise s/s</li>
                                    <li>Lack of access of health care</li>
                                    <li>Preference to traditional healers</li>
                                    <li>Fear of stigma, lack of confidence on health workers</li>
                                </ul>
                            </li>
                            <li>Reluctance to refer partners
                                <ul>
                                    <li>People with STI are reluctant to refer their partners</li>
                                </ul>
                            </li>
                            <li>Reluctance to use condoms
                                <ul>
                                    <li>Lack of familiarity with condoms</li>
                                    <li>Stigma associated with condom use</li>
                                    <li>Cultural and religious prohibition</li>
                                    <li>Fear that sex is less enjoyable</li>
                                    <li>Fear of side effects (allergy)</li>
                                </ul>
                            </li>
                        </ol>

                        <h3>Modes of transmission of STIs</h3>
                        <p><strong>Sexual Exposures</strong></p>
                        <ol class="enhanced-list">
                            <li>Unprotected sexual intercourse (over 80%)</li>
                            <li>Blood transfusion or contact with contaminated blood or blood products (3 to 5% )</li>
                            <li>Transplant of contaminated organs</li>
                            <li>Use unsterile needles skin piercing implants including surgical instrument</li>
                            <li>From mother to child during pregnancy, delivery, or breastfeeding e.g. HIV, chlamydia, gonorrhoea, herpes</li>
                        </ol>
                        <p><strong>Non sexual exposures</strong></p>
                        <ol start="6" class="enhanced-list">
                            <li>Tattooing</li>
                            <li>Traditional circumcision</li>
                            <li>Traditional delivery with unsterile equipment</li>
                            <li>Intravenous (IV) Drug Use (5-10%)</li>
                            <li>Occupational Exposure to HIV infected Material/specimens e.g. accidental needlestick injury</li>
                        </ol>
                    </div>
                </section>
                <!-- END: complications-transmission -->

                <!-- START: hiv-sti-link -->
                <section id="hiv-sti-link" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Association Between HIV/AIDS and STI/RTI</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>STI primarily disrupt the integrity of the skin/mucosal barrier, enabling HIV easy access to the body.</li>
                            <li>The presence of genital ulcers is known to increase the risk of HIV transmission by upto 10 to 100 times.</li>
                            <li>STIs that primarily cause inflammation, such as gonorrhoea, trichomoniasis, and Chlamydia, and thus weaken the skin barrier to HIV.</li>
                            <li>Increased viral shedding has been reported in genital fluids of patients with STI/RTI.</li>
                            <li>STI/RTI treatment has been demonstrated to significantly reduce HIV viral shedding.</li>
                        </ul>
                        <h3>HIV infection effect on STIs:</h3>
                        <ul class="enhanced-list">
                            <li>HIV alters the response of STIs pathogens to antibiotics. This has been reported for chancroid and syphilis.</li>
                            <li>HIV alters the clinical appearance and natural history of STI/RTI as in genital herpes and syphilis.</li>
                            <li>HIV-infected individuals have increased susceptibility to STI/RTI.</li>
                            <li>Number of sexual partners and high risk partner selection, and are associated with increased heterosexual HIV transmission.</li>
                        </ul>
                        <p>Due to this epidemiological synergy, STI/RTI control is considered a key strategy in the primary prevention of HIV transmission.</p>
                    </div>
                </section>
                <!-- END: hiv-sti-link -->

                <!-- START: classification -->
                <section id="classification" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Classification /Categories of STIs</span>
                    </h2>
                    <div class="content-card">
                        <p>There are 4 classes of STIs based on aetiology (cause);</p>
                        <ol class="enhanced-list">
                            <li>Bacterial: Chlamydia, Syphilis, Gonorrhoea</li>
                            <li>Fungal: Candidiasis</li>
                            <li>Viral: Hepatitis, Genital Herpes Simplex, HIV, Genital Warts</li>
                            <li>Protozoa: Trichomoniasis</li>
                        </ol>

                        <h3>Common STIs/STDs</h3>
                        <ol class="enhanced-list">
                            <li>Bacterial vaginosis (BV)</li>
                            <li>Chlamydia</li>
                            <li>Gonorrheoa</li>
                            <li>Syphilis</li>
                            <li>HIV</li>
                            <li>Genital ulcer disease (GUD)</li>
                            <li>Ophthalmia neonatorum</li>
                            <li>Genital herpes</li>
                            <li>Genital warts</li>
                            <li>Pubic lice</li>
                            <li>Non-specific urethritis</li>
                            <li>Candidiasis (thrush)</li>
                            <li>Trichomoniasis</li>
                            <li>Chancroid</li>
                        </ol>
                    </div>
                </section>
                <!-- END: classification -->

                <!-- START: urethral-discharge -->
                <section id="urethral-discharge" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">1. Urethral Discharge Syndrome</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>Urethral discharge is one of the most common STI/RTI syndromes among men, and is associated with serious complications.</li>
                            <li>This syndrome is commonly caused by Neisseria gonorrhoeae and Chlamydia trachomatis in over 98% of cases.</li>
                            <li>Other infectious agents include Trichomonas vaginalis, Ureaplasma urealyticum, and Mycoplasma spp.</li>
                            <li>Mixed infections, especially of Neisseria gonorrhoeae and Chlamydia trachomatis, occur.</li>
                            <li>It is characterized by purulent urethral discharge with or without dysuria.</li>
                            <li>The amount of discharge varies depending on the causative pathogens as well as prior antibiotic treatment.</li>
                            <li>If the discharge is not readily apparent, it may be necessary to milk the penis and massage it forwards before the discharge becomes apparent.</li>
                            <li>In uncircumcised patients, examination with the foreskin retracted will ascertain whether the discharge is from the urethra or from beneath the prepuce.</li>
                        </ul>

                        <h3>Management</h3>
                        <ul class="enhanced-list">
                            <li>Norfloxacin 800 mg stat (or Ciprofloxacin 500 mg stat) and Doxycycline 100 mg BD × 7 days</li>
                        </ul>
                        <p><strong>ALTERNATIVE TREATMENT</strong></p>
                        <ul class="enhanced-list">
                            <li>IM Spectinomycin 2g stat (or IM Ceftriaxone 125 - 250 mg single dose) and Doxycycline 100 mg BD × 7 days</li>
                            <li>Emphasize 4Cs - counselling, compliance, contact tracing, and condom use</li>
                            <li>Offer or refer for HIV testing services.</li>
                        </ul>

                        <aside class="callout note" role="note">
                            <h4 class="callout-title">Assignment</h4>
                            <p>Write short notes on the following STis:</p>
                            <ol class="enhanced-list">
                                <li>Gonorrhoea</li>
                                <li>Chlamydia</li>
                                <li>Candidiasis</li>
                            </ol>
                            <p>For each, include:</p>
                            <ul class="enhanced-list">
                                <li>Aetiological agent</li>
                                <li>Signs and symptoms</li>
                                <li>Laboratory test/s for the STI</li>
                                <li>Treatment</li>
                                <li>Prevention and control</li>
                            </ul>
                        </aside>
                    </div>
                </section>
                <!-- END: urethral-discharge -->

                <!-- START: gud -->
                <section id="gud" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">2. Genital Ulcer Disease (GUD)</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>Genital ulcer disease is one of the most common syndromes that affect men and women.</li>
                            <li>Genital ulcers have an epidemiologically synergistic relationship with HIV.</li>
                            <li>HIV alters the natural history of syphilis and chancroid, where more aggressive lesions may manifest.</li>
                            <li>HIV transmission, on the other hand, is enhanced in presence of ulcerative STI/RTI.</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_11_19_d298b32674afbb45dceeg-246-1.jpg" alt="Genital Ulcer Disease Presentation" class="content-image">
                        </figure>
                        <ul class="enhanced-list">
                            <li>In men, GUD occurring under the prepuce may present as a discharge.</li>
                            <li>Similarly, GUD in women may also present as a discharge, underlying the importance of clinical examination.</li>
                            <li>Genital herpes manifest with more persistent lesions.</li>
                            <li>Single or multiple ulcers can present.</li>
                        </ul>

                        <h3>a. Chancroid</h3>
                        <ul class="enhanced-list">
                            <li>Chancroid is caused by a bacterium known as Haemophilus Ducreyi.</li>
                            <li>Both males and females with chancroid develop painful genital ulcers.</li>
                            <li>In males, ulcers are commonly found on the edge of the glans-penis, but can appear anywhere on the external genitalia.</li>
                            <li>In females, ulcers may be found anywhere on the external genitalia including around the vulva, clitoris, and anus, or inside the vagina and on the cervix.</li>
                            <li>A chancroid ulcer is painful while a syphilitic ulcer is not.</li>
                        </ul>
                        <p><strong>Clinical features</strong></p>
                        <ul class="enhanced-list">
                            <li>Ulcer</li>
                            <li>Enlarged, red, hot lymph nodes in the groin, called buboes. They should be aspirated with a wide-bore needle every two days if necessary.</li>
                            <li>When a bubo is ready for aspiration, the skin overlying it is shiny and the area underneath it is soft.</li>
                        </ul>

                        <h3>b. Syphilis</h3>
                        <ul class="enhanced-list">
                            <li>The disease is caused by a bacterium known as Treponema Pallidum.</li>
                            <li>It can affect all organs of the body. It occurs in two forms: early (primary) and late syphilis.</li>
                            <li>In early syphilis a client is infectious to his/her sexual partners. During late syphilis, the client is not infectious to sexual partners.</li>
                        </ul>

                        <p><strong>1. Primary Syphilis</strong></p>
                        <ul class="enhanced-list">
                            <li>Three weeks after contact with an infected partner, the ulcer develops at the site of infection. This is the primary chancre.</li>
                            <li>It may be found anywhere on the penis in males. In females it is found on the external genitalia, the vaginal opening, inside the vagina, or on the cervix.</li>
                            <li>In both men and women, it is a painless, single, firm ulcer with a punched-out appearance.</li>
                            <li>It may heal without treatment but the client can still infect others and may develop serious cardiac and CNS symptoms later. The client needs to be treated.</li>
                        </ul>

                        <p><strong>2. Secondary Syphilis</strong></p>
                        <ul class="enhanced-list">
                            <li>Between two and four months following initial infection, clients may develop secondary syphilis.</li>
                            <li>The first sign is a non-itchy rash all over the body which may become papular(round, solid raised lesion), pustular(infected pimples), or may develop into flat warts (condylomata lata).</li>
                            <li>There may be whitish lines on the tongue and mucous membrane of the mouth called snail track ulcers. They may be generalised lymph node enlargement.</li>
                            <li>Neurologic infection- cranial nerve dysfunction, meningitis, stroke, acute or chronic altered mental status, loss of vibration sense, and auditory/ophthalmic abnormalities, which might occur through the natural history of untreated infection</li>
                        </ul>

                        <p><strong>3. Latent Syphilis</strong></p>
                        <ul class="enhanced-list">
                            <li>During this stage, there are no signs or symptoms but a blood test is positive and the client should be treated.</li>
                            <li>Untreated syphilis may progress. After two to 15 years, the heart and brain may be affected.</li>
                            <li>The patient may develop mental problems</li>
                            <li>At this time the disease cannot be passed to other people.</li>
                        </ul>

                        <h3>C. Genital Herpes</h3>
                        <ul class="enhanced-list">
                            <li>Infection is caused by the herpes simplex virus.</li>
                            <li>In males, the client develops itchiness at the site of infection. This may be on the foreskin, the shaft of the penis, or the glans-penis. A small area of redness appears which develops into small blisters. This may break down to reveal painful, shallow ulcers.</li>
                            <li>In the first attack, lesions are more extensive and cause severe pain. The attacks heal after about two to three weeks.</li>
                            <li>In females, the lesions are on the cervix, the labia, the vagina, or around the anus. During the first attack, there may be quite extensive inflammation of the cervix, the vulva, and the vagina.</li>
                            <li>Recurrence of lesions occurs in about 50% of clients; lesions are usually less extensive and heal within five to seven days.</li>
                            <li>Recurrences in both males and females may follow sexual contact and stress. In females they may also follow the menstrual period.</li>
                        </ul>
                        <p><strong>Management</strong></p>
                         <ul class="enhanced-list">
                             <li>There is no effective cure. Clients should be reassured, but warned that a recurrence of ulceration is possible and that they should not have sexual intercourse while lesions are present.</li>
                             <li>Herpes simplex virus can be passed on when there are ulcers.</li>
                             <li>Tell the client to keep the lesions clean and dry and wash with soap and water.</li>
                             <li>Erythromycin 500 mg TID × 7 days & Benzathine Penicillin 2.4 MU IM stat</li>
                             <li>If Penicillin allergy: Use Erythromycin 500 mg QID × 14 days</li>
                             <li>Alternative GUD Rx: Ciprofloxacin 500 mg single dose</li>
                         </ul>
                    </div>
                </section>
                <!-- END: gud -->

                <!-- START: vaginal-discharge -->
                <section id="vaginal-discharge" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">3. Vaginal Discharge</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>Physiological discharge: normal</strong></p>
                        <ul class="enhanced-list">
                            <li>Clear or white</li>
                            <li>Viscous in consistency</li>
                            <li>Located in the posterior fornix of the vagina</li>
                        </ul>
                        <p>Microscopy of normal vaginal secretions reveals:</p>
                        <ul class="enhanced-list">
                            <li>Superficial epithelial cells</li>
                            <li>Lactobacilli with long rods</li>
                            <li>Few white blood cells</li>
                        </ul>
                        <p>Physiologic vaginal discharge requires no Rx</p>

                        <p><strong>Abnormal Vaginal Discharge</strong></p>
                        <ul class="enhanced-list">
                            <li>Abnormal vaginal discharge is one of the most common STI/RTI syndromes among women, but also one of the most complicated to manage.</li>
                            <li>All women have a physiological vaginal discharge which may increase during certain situations.</li>
                            <li>Normally, women will only complain if they perceive the discharge to be abnormal.</li>
                        </ul>

                        <h3>Aetiology</h3>
                        <ul class="enhanced-list">
                            <li>The symptom of abnormal vaginal discharge is highly indicative of vaginitis and poorly predictive of cervicitis</li>
                            <li>Bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis are the most common causes of vaginitis</li>
                            <li>Gonococcal and chlamydial infections cause cervicitis.</li>
                        </ul>
                        <p>Distinction between the two on clinical grounds is usually difficult.</p>

                        <p><strong>Possible causes of vaginal discharge</strong></p>
                        <ol class="enhanced-list">
                            <li>Neisseria Gonorrhoea-Greenish-yellow discharge</li>
                            <li>Chlamydia trachomatis- Scanty muco-purulent or purulent discharge</li>
                            <li>Trichomonas vaginalis- Frothy, profuse, greenish-yellow foul-smelling discharge</li>
                            <li>Candida albicans-White, curd-like discharge</li>
                            <li>Gardnerella vaginalis- Profuse foul-smelling and homogenous greyish-white discharge</li>
                        </ol>

                        <h3>Management</h3>
                        <p>Offer or refer for HIV testing services</p>
                        <p><strong>VAGINITIS Rx</strong></p>
                        <ul class="enhanced-list">
                            <li>Clotrimazole 1 pessary intravaginally daily for 6 days Or</li>
                            <li>Clotrimazole 200 mgs pessaries intravaginally daily for 3 days) AND Metronidazole 400 mg</li>
                        </ul>
                        <p>If pregnant</p>
                        <ul class="enhanced-list">
                            <li>Clotrimazole 1 pessary intravaginally daily $\times 6$ days</li>
                            <li>Or</li>
                            <li>Clotrimazole 200 mgs pessaries intravaginally daily for 3 days)</li>
                        </ul>

                        <p><strong>Cervicitis Rx</strong></p>
                        <ul class="enhanced-list">
                            <li>Norfloxacin 800 mg stat (or Ciprofloxacin 500 mg stat) & Doxycycline 100 mg BD × 7 days</li>
                        </ul>
                        <p>IF PREGNANT</p>
                        <ul class="enhanced-list">
                            <li>IM Spectinomycin 2gm stat (or IM Ceftriaxone 250 mg single dose) & Erythromycin 500 mg QID $\times 7$ days</li>
                        </ul>
                    </div>
                </section>
                <!-- END: vaginal-discharge -->

                <!-- START: pid -->
                <section id="pid" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">4. Lower Abdominal Pain Syndrome (PID)</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>This is one of the most common and most serious STI syndromes among women, with very serious reproductive health and socioeconomic consequences.</li>
                            <li>PID comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis</li>
                        </ul>
                        <p><strong>Causes</strong></p>
                        <ul class="enhanced-list">
                            <li>Sexually transmitted organisms, especially N. gonorrhoeae and C. trachomatis, are implicated in many cases; however, microorganisms that comprise the vaginal flora (e.g., anaerobes, G. vaginalis, Haemophilus influenzae, enteric Gram-negative rods, and Streptococcus agalactiae) have been associated with PID</li>
                        </ul>
                        <p><strong>Clinical manifestations</strong></p>
                        <ul class="enhanced-list">
                            <li>Abdominal pain,</li>
                            <li>abnormal cervical or vaginal mucopurulent vaginal bleeding</li>
                            <li>Dyspareunia</li>
                            <li>fever, and sometimes vomiting.</li>
                        </ul>
                        <aside class="callout note" role="note">
                             <h4 class="callout-title">Note</h4>
                             <p>Patients should be carefully evaluated for abdominal tenderness, cervical motion and adnexial tenderness, enlargement of uterine tubes, and tender pelvic masses.</p>
                        </aside>

                        <h3>Management</h3>
                        <ul class="enhanced-list">
                            <li>Norfloxacin 800 mg stat (or Ciprofloxacin 500 mg single dose)</li>
                            <li>Doxycycline 100 mg BD × 7 days</li>
                            <li>Metronidazole 400 mg BD × 10 days</li>
                        </ul>
                        <p>If pregnant:</p>
                        <ul class="enhanced-list">
                            <li>Refer for obstetric evaluation if PID is suspected</li>
                        </ul>
                        <p>ALTERNATIVE TREATMENT</p>
                        <ul class="enhanced-list">
                            <li>Azithromycin 1 gm PO single dose or</li>
                            <li>Cefixime 400 mg PO single dose</li>
                            <li>Offer or refer for HIV testing services.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: pid -->

                <!-- START: ophthalmia-neonatorum -->
                <section id="ophthalmia-neonatorum" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">5. Ophthalmia Neonatorum</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>This refers to conjunctival infection of neonates.</li>
                            <li>Neonates acquire this infection during passage through an infected birth canal during delivery.</li>
                            <li>Occurs between 4-7 days of life, but can occur anytime in the first 28 days.</li>
                            <li>Caused by Neisseria gonorrhoea(GC) or Chlamydia trachomatis(Chlamydia).</li>
                        </ul>
                        <p><strong>Clinical manifestations</strong></p>
                        <ul class="enhanced-list">
                            <li>This disease is often characterized by bilateral purulent eye discharge. In early stages, the discharge may be "sticky," causing the eyelids to be stuck together in the morning, rather than the thick, greenish pus seen later.</li>
                            <li>The conjunctiva is inflamed and eyelids swollen.</li>
                            <li>Corneal scarring may occur if treatment is delayed.</li>
                            <li>Blindness in children is associated with high infant morbidity and mortality.</li>
                        </ul>
                        <p><strong>Treatment</strong></p>
                        <ul class="enhanced-list">
                            <li>1% TETRACYCLINE eye ointment TDS × 10 days</li>
                            <li>Treat mother for cervicitis and partner for urethritis</li>
                        </ul>
                        <p>Alternative</p>
                        <ul class="enhanced-list">
                            <li>Ceftriaxone 62.5 mg IM stat and 1%</li>
                            <li>Tetracycline eye ointment TDS × 10 days and 4Cs</li>
                        </ul>
                    </div>
                </section>
                <!-- END: ophthalmia-neonatorum -->

                <!-- START: other-syndromes -->
                <section id="other-syndromes" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">6. OTHER STI SYNDROMES</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li>Inguinal Buboes</li>
                            <li>Painful scrotal swelling</li>
                            <li>Balanitis</li>
                            <li>Bartholin'sabscess</li>
                            <li>Genital warts</li>
                            <li>Congenital syndromes</li>
                        </ul>

                        <h3>Genital warts</h3>
                        <ul class="enhanced-list">
                            <li>Genital warts are caused by a virus -human papilloma virus.</li>
                            <li>They usually have the appearance of flesh-coloured cauliflower-like growths on the genitals.</li>
                            <li>The penis and foreskin (men) and the labia or vagina (women) are the most common sites of the warts.</li>
                            <li>The warts can be variable in number and size, either few or multiple, small to very large.</li>
                        </ul>
                        <p><strong>Clinical manifestations</strong></p>
                        <ul class="enhanced-list">
                            <li>Are usually asymptomatic, but depending on the size and anatomic location, they can be painful or pruritic.</li>
                            <li>Genital warts are usually flat, papular, or pedunculated growths on the genital mucosa</li>
                            <li>Genital warts occur commonly at the introitus in women, under the foreskin of the uncircumcised penis, and on the shaft of the circumcised penis.</li>
                        </ul>
                        <p><strong>Management</strong></p>
                        <ul class="enhanced-list">
                            <li>Warts are treated with local application of podophyllin(10-25% solution) once a week.</li>
                            <li>After treatment of warts, the medication must be washed off within 2-4 hours to avoid developing sores at the site of treatment.</li>
                            <li>Podofilox 0.5% solution or gel</li>
                            <li>OR Imiquimod 5% cream</li>
                            <li>OR Sinecatechins 15% ointment</li>
                        </ul>
                    </div>
                </section>
                <!-- END: other-syndromes -->

                <!-- START: prevention-control -->
                <section id="prevention-control" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Prevention and Control of STIs</span>
                    </h2>
                    <div class="content-card">
                        <p>The prevention and control of STIs are based on the following five major strategies:</p>
                        <ol type="i" class="enhanced-list">
                            <li>Education and counseling of persons at risk on ways to avoid STIs through changes in sexual behaviors and use of recommended prevention services.</li>
                            <li>Identification of asymptomatically infected persons and of symptomatic persons unlikely to seek diagnostic and treatment services.</li>
                            <li>Effective diagnosis, treatment, and counseling of infected persons.</li>
                            <li>Evaluation, treatment, and counseling of sexual partners of persons who are infected with an STD</li>
                            <li>Barrier methods - the consistent use of condoms</li>
                            <li>Pre-exposure vaccination of persons at risk for vaccine-preventable STIs. Vaccines are available for 2 STIs - Hepatitis B and HPV</li>
                        </ol>

                        <h3>1. Primary Prevention</h3>
                        <ul class="enhanced-list">
                            <li>Primary prevention of STIs begins with promoting changes to risky sexual behaviors that increase the risk of infection.</li>
                            <li>Health care providers have a unique opportunity to provide education and counseling to their patients.</li>
                            <li>As part of the clinical interview, health care providers should routinely and regularly obtain sexual histories from their patients and address management of risk reduction.</li>
                        </ul>
                        <p><strong>Primary Preventive Measures</strong></p>
                        <ol class="enhanced-list">
                            <li>Abstinence: This might be total abstinence from sex or, for groups such as students and youth not yet married, one should encourage "postponed sex" till one is ready for marriage.</li>
                            <li>Mutual monogamy: Mutually faithful sexual relationship or what is usually termed as "Zero grazing" if both partners are not already infected.</li>
                            <li>Correct and consistent use of condoms: This intervention is recommended for those who cannot abstain and yet cannot have a mutually faithful relationship.</li>
                            <li>Safer sex practices: Safer sex practices are many and varied but all revolve around the principle of avoiding exchange of sexual or body fluids, yet enabling the individual(s) to obtain what they desire out of sex. Use of condoms is an important safe sex practice</li>
                        </ol>

                        <h3>2. Secondary Prevention</h3>
                        <ul class="enhanced-list">
                            <li>Secondary prevention curtails STIs onset and transmission through early diagnosis and treatment.</li>
                            <li>Risk-reduction counseling must screen clients for infection, discourage risky sexual activities, and encourage partner notification of infections.</li>
                            <li>Patient-initiated partner notification may encourage partner referral for STIs etiological evaluation and treatment.</li>
                            <li>Where appropriate laboratory facilities for investigations are unavailable the syndromic management approach is recommended.</li>
                        </ul>
                        <ol class="enhanced-list">
                            <li>Early diagnosis and prompt and correct treatment of STI</li>
                            <li>Promotion of STI care-seeking behaviour, including reduction of barriers to care</li>
                            <li>Notification of partners and treatment/contact tracing</li>
                            <li>Screening for asymptomatic cases</li>
                        </ol>

                        <h3>3. Tertiary Prevention</h3>
                        <ul class="enhanced-list">
                            <li>Tertiary prevention requires medical treatment focuses on reduction of local complications (e.g. urethral stricture) or systemic complications (e.g. pelvic inflammatory diseases and AIDS), and sequelae associated with untreated or incompletely treated infections.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: prevention-control -->

                <!-- START: vulnerable-groups -->
                <section id="vulnerable-groups" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Risk Factors and Vulnerable Groups</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>Risk factors for STIs acquisition and transmission</strong></p>
                        <ol class="enhanced-list">
                            <li>Participation in unprotected vaginal, oral or anal sex(no condom used)</li>
                            <li>Genital to genital sexual contact</li>
                            <li>Previous history of STIs</li>
                            <li>Having multiple sexual partners</li>
                            <li>Use of non-barrier contraceptives, such as</li>
                            <li>Spermicides especially those containing n-9 due to disruption of the genital epithelium</li>
                            <li>Use of injection drugs, alcohol or other substances that can impair decision making ability</li>
                            <li>Use of prep which may lead to decreased use of condoms hence increased risk</li>
                            <li>Inconsistent and irregular use of condoms during sex</li>
                            <li>Vaginal practices e.g. Douching</li>
                            <li>Group sex</li>
                        </ol>

                        <p><strong>Vulnerable groups / Risk factors for STIs</strong></p>
                        <ol class="enhanced-list">
                            <li>Having primary education or less for an individual and/or their spouse</li>
                            <li>Lack of formal employment</li>
                            <li>Poverty</li>
                            <li>Low income</li>
                            <li>Alcohol and substance abuse</li>
                            <li>Individuals and/or partners with multiple sex partners</li>
                            <li>Gender based violence</li>
                            <li>Mental and physical disability</li>
                            <li>Childhood sexual abuse</li>
                            <li>Child marriage</li>
                            <li>Out of school adolescents</li>
                            <li>Early sexual debut</li>
                            <li>Disempowerment of women</li>
                            <li>People living with hiv</li>
                            <li>Conflict situations</li>
                            <li>Refugees/internally displaced persons and immigrants</li>
                        </ol>
                    </div>
                </section>
                <!-- END: vulnerable-groups -->

                <!-- START: management-approach -->
                <section id="management-approach" class="content-section">
                    <h2 class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Management Approach</span>
                    </h2>
                    <div class="content-card">
                        <p>STIs can be managed through aetiological, clinical and syndromic approaches; or through a combination of these approaches. The management of any STI through all of these approaches should follow these standard steps:</p>
                        <ol class="enhanced-list">
                            <li>History taking</li>
                            <li>Physical examination</li>
                            <li>Establishment of diagnosis and treatment plan</li>
                            <li>Education and counseling to prevent re-infection</li>
                            <li>Education and counseling to enhance compliance</li>
                            <li>Condom promotion, demonstration and dispensing</li>
                            <li>Assisted partner notification</li>
                        </ol>
                        <p>The last 4 steps are commonly referred to as 4Cs namely: Counseling, Compliance, Condoms and Contact Tracing. In addition, irrespective of the approach of management used, all STI patients should be provided with HIV testing services.</p>

                        <h3>What are the 4 cs ?</h3>
                        <ol type="i" class="enhanced-list">
                            <li><strong>Counseling :</strong> Empathize with the patient</li>
                            <li><strong>Compliance:</strong> Your patients should avoid self medication, take full course of medicine and not share and follow instructions as advised.</li>
                            <li><strong>Contact tracing:</strong> Encourage disclosure and tell her or his sexual,partners to seek medication</li>
                            <li><strong>Condoms</strong></li>
                        </ol>
                    </div>
                </section>
                <!-- END: management-approach -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="05-sbcc-and-hbc.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                       <span class="progress-text">Part 6 of 6</span>
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>